Jason T. Johnson

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

David McDonnell, Holland C. Detke, Richard F. Bergstrom et al. · BMC Psychiatry · 2010 · 94 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)

Chafiq Hamdouchi, Steven D. Kahl, Anjana Patel Lewis et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection

Stephen C. Kasper, Edward L. Mattiuz, Steven P. Swanson et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1999 · 46 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15

Disposition and Metabolism of LY2452473, a Selective Androgen Receptor Modulator, in Humans

Ping Yi, Jessica Rehmel, Kenneth C. Cassidy et al. · Drug Metabolism and Disposition · 2012 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +14

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

Malcolm I. Mitchell, Prajakti A. Kothare, Richard Bergstrom et al. · Clinical Therapeutics · 2013 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +16